O. Wang

590 total citations
19 papers, 372 citations indexed

About

O. Wang is a scholar working on Nephrology, Genetics and Oncology. According to data from OpenAlex, O. Wang has authored 19 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 6 papers in Genetics and 5 papers in Oncology. Recurrent topics in O. Wang's work include Parathyroid Disorders and Treatments (6 papers), Bone health and treatments (5 papers) and Connective tissue disorders research (4 papers). O. Wang is often cited by papers focused on Parathyroid Disorders and Treatments (6 papers), Bone health and treatments (5 papers) and Connective tissue disorders research (4 papers). O. Wang collaborates with scholars based in China, United States and United Kingdom. O. Wang's co-authors include Weibo Xia, Xiaoping Xing, Yan Jiang, Ke Li, Li Xu, Ruizhi Jiajue, Jian Yin, Fang Lv, W. Yu and Min Nie and has published in prestigious journals such as Osteoporosis International, Diabetic Medicine and Journal of the International Neuropsychological Society.

In The Last Decade

O. Wang

18 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Wang China 10 141 114 102 98 85 19 372
Anastasia Dede Greece 8 237 1.7× 89 0.8× 80 0.8× 158 1.6× 127 1.5× 8 493
Hirokazu Okada Japan 11 133 0.9× 54 0.5× 106 1.0× 107 1.1× 66 0.8× 24 458
Adalbert Raimann Austria 13 54 0.4× 126 1.1× 58 0.6× 98 1.0× 98 1.2× 51 405
Panagiota Andreopoulou United States 7 121 0.9× 75 0.7× 103 1.0× 98 1.0× 225 2.6× 11 476
Dorica Cataldo Italy 6 158 1.1× 91 0.8× 133 1.3× 222 2.3× 86 1.0× 9 479
Morten Frost Nielsen Denmark 6 84 0.6× 66 0.6× 47 0.5× 83 0.8× 107 1.3× 13 296
Ruizhi Jiajue China 8 115 0.8× 58 0.5× 37 0.4× 80 0.8× 108 1.3× 30 316
Ivana Pulvirenti Italy 7 313 2.2× 55 0.5× 52 0.5× 279 2.8× 172 2.0× 7 527
H. Brockstedt Denmark 8 196 1.4× 46 0.4× 53 0.5× 102 1.0× 124 1.5× 11 336
Sabashini K. Ramchand Australia 11 155 1.1× 70 0.6× 49 0.5× 101 1.0× 174 2.0× 28 347

Countries citing papers authored by O. Wang

Since Specialization
Citations

This map shows the geographic impact of O. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Wang more than expected).

Fields of papers citing papers by O. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Wang. The network helps show where O. Wang may publish in the future.

Co-authorship network of co-authors of O. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of O. Wang. A scholar is included among the top collaborators of O. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Wang. O. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wang, Yawen, Jing Hu, Xiaoting Lin, et al.. (2024). Correlation of serum DKK1 level with skeletal phenotype in children with osteogenesis imperfecta. Journal of Endocrinological Investigation. 47(11). 2785–2795.
2.
Wang, O., Luciana Mascarenhas Fonseca, Michael J. Cleveland, et al.. (2023). 4 Associations Between Glycemia and Cognitive Performance in Adults with Type 1 Diabetes (T1D) using Continuous Glucose Monitoring (CGM) and Ecological Momentary Assessment (EMA). Journal of the International Neuropsychological Society. 29(s1). 792–793. 1 indexed citations
3.
Qi, Wei, Ruizhi Jiajue, Qi Pang, et al.. (2023). Deteriorated bone microarchitecture caused by sympathetic overstimulation in pheochromocytoma and paraganglioma. Journal of Endocrinological Investigation. 47(4). 843–856. 1 indexed citations
4.
Song, An, Hongyan Zhao, Yuejin Yang, et al.. (2021). Safety and efficacy of common vitamin D supplementation in primary hyperparathyroidism and coexistent vitamin D deficiency and insufficiency: a systematic review and meta-analysis. Journal of Endocrinological Investigation. 44(8). 1667–1677. 19 indexed citations
5.
Jiang, Yan, et al.. (2020). The genetic polymorphisms of XPR1 and SCL34A3 are associated with Fanconi syndrome in Chinese patients of tumor-induced osteomalacia. Journal of Endocrinological Investigation. 44(4). 773–780. 5 indexed citations
6.
Yuan, Xun, Xueyan Wu, Xiaoping Xing, et al.. (2020). Successful treatment of diabetes associated with glycogen storage disease type Ia. Diabetic Medicine. 38(2). e14373–e14373. 2 indexed citations
7.
Zhao, Zhen, Fan Ping, Xiangping Chai, et al.. (2020). Iron deficiency plays essential roles in the trigger, treatment, and prognosis of autosomal dominant hypophosphatemic rickets. Osteoporosis International. 32(4). 737–745. 7 indexed citations
8.
Wang, W., Min Nie, Yan Jiang, et al.. (2019). Impaired geometry, volumetric density, and microstructure of cortical and trabecular bone assessed by HR-pQCT in both sporadic and MEN1-related primary hyperparathyroidism. Osteoporosis International. 31(1). 165–173. 20 indexed citations
9.
Jiang, Yan, Juan Du, Yingna Song, et al.. (2019). Novel SLCO2A1compound heterozygous mutation causing primary hypertrophic osteoarthropathy with Bartter-like hypokalemia in a Chinese family. Journal of Endocrinological Investigation. 42(10). 1245–1252. 4 indexed citations
10.
Cui, Lü, Tianhua He, Yan Jiang, et al.. (2019). Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data. Osteoporosis International. 31(2). 307–316. 15 indexed citations
11.
Song, Yuwen, Fei Zhao, Xin‐Jian Xu, et al.. (2018). Novel compound heterozygous mutations in SERPINH1 cause rare autosomal recessive osteogenesis imperfecta type X. Osteoporosis International. 29(6). 1389–1396. 13 indexed citations
12.
Sun, Juan, Ruizhi Jiajue, O. Wang, et al.. (2018). Mutation update and long-term outcome after treatment with active vitamin D3 in Chinese patients with pseudovitamin D-deficiency rickets (PDDR). Osteoporosis International. 30(2). 481–489. 7 indexed citations
13.
Cui, Lü, Weibo Xia, Yan Jiang, et al.. (2017). Vertebral fracture in postmenopausal Chinese women: a population-based study. Osteoporosis International. 28(9). 2583–2590. 47 indexed citations
14.
Asan, Dexuan Ma, Fang Lv, et al.. (2017). Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing. Osteoporosis International. 28(10). 2985–2995. 63 indexed citations
15.
Lv, Fang, W. F. Mader, Wei Liu, et al.. (2017). A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid. Osteoporosis International. 28(9). 2691–2700. 22 indexed citations
16.
Xu, Lingling, Weihong Yu, Bin Qu, et al.. (2017). Serum ZAG Levels Were Associated with eGFR Mild Decrease in T2DM Patients with Diabetic Nephropathy. International Journal of Endocrinology. 2017. 1–7. 9 indexed citations
17.
Wang, O., Ying Hu, Qingyun Xue, et al.. (2015). A survey of outcomes and management of patients post fragility fractures in China. Osteoporosis International. 26(11). 2631–2640. 51 indexed citations
18.
Jiajue, Ruizhi, Yan Jiang, O. Wang, et al.. (2014). Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus. Osteoporosis International. 25(8). 1999–2005. 66 indexed citations
19.
Copley, J. Brian, Michael J. Germain, Leonard Stern, et al.. (2010). Evaluation of Cinacalcet HCl Treatment After Kidney Transplantation. Transplantation Proceedings. 42(7). 2503–2508. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026